Singapore markets closed

Swedish Orphan Biovitrum AB (publ) (SOBIS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
279.600.00 (0.00%)
At close: 04:14PM BST
Currency in SEK

Valuation measures4

Market cap (intra-day) 93.10B
Enterprise value 109.42B
Trailing P/E 44.74
Forward P/E 27.40
PEG ratio (5-yr expected) 1.30
Price/sales (ttm)4.02
Price/book (mrq)2.64
Enterprise value/revenue 4.61
Enterprise value/EBITDA 14.08

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 337.33%
S&P500 52-week change 323.23%
52-week high 3290.60
52-week low 3203.60
50-day moving average 3273.43
200-day moving average 3259.16

Share statistics

Avg vol (3-month) 34
Avg vol (10-day) 38
Shares outstanding 5342.53M
Implied shares outstanding 6346.43M
Float 8218.79M
% held by insiders 110.08%
% held by institutions 172.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 9.05%
Operating margin (ttm)11.82%

Management effectiveness

Return on assets (ttm)3.88%
Return on equity (ttm)6.63%

Income statement

Revenue (ttm)23.71B
Revenue per share (ttm)70.24
Quarterly revenue growth (yoy)11.70%
Gross profit (ttm)N/A
EBITDA 8.03B
Net income avi to common (ttm)2.14B
Diluted EPS (ttm)6.26
Quarterly earnings growth (yoy)0.90%

Balance sheet

Total cash (mrq)779M
Total cash per share (mrq)2.27
Total debt (mrq)17.1B
Total debt/equity (mrq)47.03%
Current ratio (mrq)0.73
Book value per share (mrq)106.08

Cash flow statement

Operating cash flow (ttm)6.72B
Levered free cash flow (ttm)5.66B